- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02816723
Mindfulness Training in Healthy Older Veterans (MTGHOV)
March 24, 2020 updated by: VA Office of Research and Development
Improving Brain Health in Older Veterans: A Mindfulness Training Pilot Study
Evidence shows the positive effects of Brain Health & Wellness classes in younger individuals.
The proposed study investigates the usefulness of these classes in older Veterans aged 50-85.
We hope to show that such classes can lead to improvements in both thinking skills as well as stress levels.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The expansion of the aging Veteran population, in addition to the frequent presence of comorbidities (e.g., PTSD and TBI) that exacerbate age-associated cognitive and health declines, has generated substantial interest in interventions that promote brain health in older Veterans.
A growing body of evidence shows the positive effects of Brain Health & Wellness classes on brain health in younger and middle-aged adults, thus training might be able to enhance brain health in older Veterans and offset age-related declines.
Such training holds particular promise in enhancing areas of cognition that are especially susceptible to aging processes (e.g.
attention and executive control), potentially through multiple mechanistic pathways.
It is in many respects a cognitive exercise and may strengthen neural networks involved in such processes.
Additionally, there is evidence for further facilitating brain health in other ways related to, for instance, altering the stress response.
Currently, there is little information regarding the potential brain health benefits in older adults.
As a first step to understanding these potential beneficial effects in Veterans, the aim of the proposed pilot study is to evaluate the acceptability, feasibility and potential efficacy of two Brain Health & Wellness classes in healthy older Veterans through a randomized, controlled trial.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Sacramento, California, United States, 95655
- VA Northern California Health Care System, Mather, CA
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
46 years to 81 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subjects will be Veterans age 50-85
Exclusion Criteria:
- moderate or severe TBI
- active alcohol or drug dependence or abuse by DSM-5 criteria (within previous 30 days)
- positive urine drug screen for illicit substances
- history of schizophrenia
- ADHD
- learning disability
- dementia
- Mild Cognitive Impairment and/or other psychiatric disturbances not including PTSD and/or depression
- participants with a history of psychiatric hospitalization (last five years)
- suicide attempt (last five years)
- imminent risk for suicidal or homicidal behavior, or severe medical illness requiring treatment will be excluded
subjects with a history of neurological diagnosis, e.g.,:
- brain tumor
- clinical stroke
- seizure
- Mini-Mental Status Exam score below 19 (suggesting moderate/severe cognitive impairment, a contraindication to MBSR participation) will be excluded
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mindfulness
mindfulness/meditation/movement training
|
mindfulness/meditation/movement training
Other Names:
|
|
Active Comparator: Brain Health
Brain Health education class
|
Brain Health Education
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Geriatric Depression Scale Change Score
Time Frame: Baseline (within two weeks pre-intervention) and Outcome at 2 months (within 2 weeks post-intervention)
|
Participants' scores on the Geriatric Depression Scale were collected within 2 weeks before the intervention and again within 2 weeks after the intervention.
This outcome measure represents the change in score in Geriatric Depression Scale: pre-intervention score minus post-intervention score.
The maximum Geriatric Depression Scale score is 30, and the minimum score is 0. Higher scores on the Geriatric Depression Scale indicate more depressive symptoms, so worse outcome.
However, since we are analyzing a change in the Geriatric Depression Scale score of pre- minus post-intervention, a larger change score for a particular arm indicates a greater degree of improvement.
|
Baseline (within two weeks pre-intervention) and Outcome at 2 months (within 2 weeks post-intervention)
|
|
State-Trait Anxiety Inventory (STAI) Change Score
Time Frame: Baseline (within two weeks pre-intervention) and Outcome at 2 months (within 2 weeks post-intervention)
|
Participants' scores on the State-Trait Anxiety Inventory (STAI) were collected within 2 weeks before the intervention and again within 2 weeks after the intervention.
This outcome measure represents the change in score in State-Trait Anxiety Inventory: pre-intervention score minus post-intervention score.
The maximum STAI score is 80, and the minimum score is 20.
Higher scores on the STAI indicate more anxiety symptoms, so worse outcome.
However, since we are analyzing a change in the STAI score of pre- minus post-intervention, a larger change score for a particular arm indicates a greater degree of improvement.
|
Baseline (within two weeks pre-intervention) and Outcome at 2 months (within 2 weeks post-intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Repeatable Battery for Neuropsychological Status (RBANS) Total Scaled Change Score
Time Frame: Baseline (within two weeks pre-intervention) and Outcome at 2 months (within 2 weeks post-intervention)
|
Participants' scores on the Repeatable Battery for Neuropsychological Status (RBANS) were collected within 2 weeks before the intervention and again within 2 weeks after the intervention.
The maximum total scaled score is 160, and the minimum score is 40, where higher scores are better.
This outcome measure represents the change in total scaled score on the RBANS: post-intervention score minus pre-intervention score.
A higher change score for a particular arm indicates a greater degree of improvement.
|
Baseline (within two weeks pre-intervention) and Outcome at 2 months (within 2 weeks post-intervention)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 28, 2016
Primary Completion (Actual)
May 30, 2019
Study Completion (Actual)
July 31, 2019
Study Registration Dates
First Submitted
June 24, 2016
First Submitted That Met QC Criteria
June 24, 2016
First Posted (Estimate)
June 28, 2016
Study Record Updates
Last Update Posted (Actual)
April 7, 2020
Last Update Submitted That Met QC Criteria
March 24, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- E2398-P
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Florida Institute for Human and Machine CognitionNot yet recruitingAging | Healthy Aging | Aging WellUnited States
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
University of CopenhagenRecruitingAging | Healthy Aging | Aging FrailtyDenmark
-
Radboud University Medical CenterTerminated
-
Northwestern UniversityPotocsnak Human Longevity LabRecruitingAging | Aging Well | Aging, Biological | Aging, HealthyUnited States
-
Centre Hospitalier Universitaire de NiceNot yet recruitingAging | Aging Disorder | Aging, HealthyFrance
-
Centre Hospitalier Universitaire de NiceNot yet recruitingAging | Aging, HealthyFrance
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
Arizona State UniversityActive, not recruiting
Clinical Trials on Mindfulness-based Stress Reduction
-
Duke UniversityNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Inflammation | Stress, Psychological | SleepUnited States
-
University of California, San FranciscoCompletedDementia | Frontotemporal Dementia | Frontotemporal Lobar Degeneration | Caregiver Stress Syndrome | Caregiver Burnout | Dementia Frontal | Mindfulness Based Stress ReductionUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingChronic Low-back PainUnited States
-
Oregon Health and Science UniversityPortland VA Medical CenterCompleted
-
Fatima Jinnah Women UniversityRecruitingBehavior Problem | Emotional ProblemPakistan
-
Fatima Jinnah Women UniversityNot yet recruitingPsychological StressPakistan
-
University of PaviaUniversity of Siena, ItalyCompletedWell-being | Work-Related Stress | Employees of University | Inflammation StatusItaly
-
Toronto Metropolitan UniversityCompleted
-
Saglik Bilimleri UniversitesiCompletedObesity | Polycystic Ovary Syndrome | StressTurkey
-
Medicos e Investigadores en la Lucha contra el...CompletedBreast Cancer | Anxiety | SurvivorshipMexico